| Activity |
| Catalytic type | Metallo |
| Peplist | Included in the Peplist with identifier PL00161 |
| NC-IUBMB | Subclass 3.4 (Peptidases) >> Sub-subclass 3.4.24 (Metalloendopeptidases) >> Peptidase 3.4.24.23
|
| Enzymology | BRENDA database |
| Proteolytic events | CutDB database (89 cleavages) |
| Activity status | human: active (Woessner, 2004) mouse: active (Crabbe et al., 1992)
|
| Physiology | Role in turnover of extracellular matrix proteins. |
| Knockout | Suppression of expression of matrilysin by antisense methods has shown depression of invasive potential of cancer cells (Yamamoto et al., 1995; Miyazaki et al., 1999). Also, matrilysin knockout mice were dramatically protected from bleomycin-induced pulmonary fibrosis (Zuo et al., 2002). |
| Pharmaceutical relevance | Drug target for prevention of pathological tissue damage. Research data suggest that matrilysin plays an important role in leukaemia cell invasion (Lynch & McDonnell, 2001). |
|
Other databases
| WIKIPEDIA | http://en.wikipedia.org/wiki/MMP7 |
| Cleavage site specificity |
Explanations of how to interpret the
following cleavage site sequence logo and specificity matrix can be found here. |
| Cleavage pattern | -/pa/-/- L/-/-/- (based on 196 cleavages) |